title: Viewpoint: Challenges and opportunities in tuberculosis research.
authors.affiliation: TB Clinical Research Team, Therapeutics Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA. kimp2@niaid.nih.gov
authors.forename: Peter S
authors.initials: PS
authors.lastname: Kim
authors.forename: Mamodikoe
authors.initials: M
authors.lastname: Makhene
authors.forename: Christine
authors.initials: C
authors.lastname: Sizemore
authors.forename: Richard
authors.initials: R
authors.lastname: Hafner
mesh_terms: D000375:Aging; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015415:Biomarkers; D002986:Clinical Trials as Topic / Q000379:methods; D015658:HIV Infections / Q000150:complications* / Q000453:epidemiology* / Q000401:mortality; D006801:Humans; D009169:Mycobacterium tuberculosis; D009930:Organic Chemicals; D058873:Pandemics; D012106:Research / Q000191:economics / Q000639:trends; D012107:Research Design; D014376:Tuberculosis / Q000150:complications* / Q000453:epidemiology / Q000401:mortality / Q000517:prevention & control*; D032581:Tuberculosis Vaccines
chemical_list: D019380:Anti-HIV Agents; D000995:Antitubercular Agents; D015415:Biomarkers; C111192:Inmodulen; D009930:Organic Chemicals; D032581:Tuberculosis Vaccines